newsfilter
← Latest News
Business Wire·

Revance Announces Pricing of $100.0 Million Public Offering of Common Stock

Revance Therapeutics, Inc. (NASDAQ:RVNC) ("Revance" or the "Company") today announced the pricing of an underwritten public offering of 16,000,000 shares of its common stock. The shares of common stock are being offered